The largest database of trusted experimental protocols

4 protocols using cd19 apc hib19

1

PBMC Subpopulations and CCR6 Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry analysis was performed to identify PBMC subpopulations and surface expression of CCR6. One million cells from each of the 40 subjects were incubated with human Fc Receptor binding inhibitor from eBioscience (Thermo Fisher Scientific, Waltham, MA, USA) for 20 min. Cell were further stained for 30 min at room temperature with the following anti-human antibodies: CD8a PerCP (HIT8a), CD14 Pacific Blue (HCD14) and CD19 APC (HIB19) from BioLegend (San Diego, CA, USA), CD4 FITC (RPA-T4) from eBioscience (Thermo Fisher Scientific, Waltham, MA, USA) and CCR6 PE (11A9) or isotype control IgG1κ PE (MOPC-21) and CD16 APC-H7 (3G8) from BD Bioscience (Franklin Lakes, NJ, USA). After incubation with fix/lysis buffer from eBioscience (Thermo Fisher Scientific, Waltham, MA, USA) for 10 min at room temperature, cells were washed twice in FACS buffer (PBS with 0.1% BSA) and resuspended in PBS. Compensation controls were prepared using Anti-mouse Igκ/Negative Control Compensation Particle Set from BD Bioscience (Franklin Lakes, NJ, USA) according to the manufacturer’s recommendations. Flow cytometry was performed on a BD FACS Canto II flow cytometer with FACS Diva software from BD Bioscience (Franklin Lakes, NJ, USA) (10,000 events per sample) and samples were analysed using FlowJo v10 software from Flow Jo, LLC (Ashland, OR, USA).
+ Open protocol
+ Expand
2

Comprehensive Immune Profiling of CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAR T cells (2×105 cells per test) were labeled with antibodies at 4°C for 15 min. Flow cytometry was performed using a MACSQuant Analyser 10 Flow Cytometer (Miltenyi Biotec, Bergisch Gladbach, Germany), and data were analyzed by FlowJo V.10.7.1 software (FlowJo). Cells were subjected to SSc-FSc and gated as the CD3+ T-cell population. For transfection efficiency: CD19 CAR detection reagent, anti-biotin PE, and CD3-APC (Miltenyi Biotec, Bergisch Gladbach, Germany); T-cell phenotype: CD3-PerCP (UCHT1), CD8-PE (SK1), (BD Bioscience, New Jersey, USA), CD4-APC (BioLegend, San Diego, California, USA); memory phenotype: CD3-PerCP (UCHT1), CD45RO-VioGreen (UCHL1), and CD62L-VioBlue (DREG-56) (BD Bioscience, New Jersey, USA); exhaustion: CD3-PerCP, PD1(CD279)-APC, TIM-3-PE, LAG3-PE, and TIGIT-APC (BioLegend, San Diego, California, USA); activation: CD3-PerCP, CD25-PE, and CD69-APC (BioLegend, San Diego, California, USA); and for cytolytic activity: CD3-PE (OKT3), CD19-APC (HIB19) (BioLegend, San Diego, California, USA), and 7AAD-PerCP (BD Bioscience, New Jersey, USA).
+ Open protocol
+ Expand
3

Phenotypic Characterization of Plasma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were stained with: CD3‐FITC (BW264/56, #130‐080‐401, Miltenyi Biotec), CD19‐APC (HIB19, #302212, BioLegend), CD38‐PE (IB6, #130‐092‐260, Miltenyi Biotec), CCR10‐APC (REA326, #130‐104‐821, Miltenyi Biotec), β7‐BV421 (FIB504, #564283, BD Bioscience), BCMA‐PE (19F2, #357504, Biolegend), TACI‐APC (1A1, #311912, Biolegend), IL10‐R‐Bv421 (3F9, #742942, BD Biosciences), BAFF‐R‐PE (11C1, #316906, Biolegend), CD138‐APC (44F9, # 130‐098‐746, Miltenyi), and Fixable Viability Dye eFluor 506 (#65‐0866‐14, eBioscience). IL‐6 and IL‐10 levels in supernatants were assessed using the BD Human Flex set (#558276 (IL‐10), #558274 (IL‐6) BD Biosciences) according to the manufacturer's instructions. IgM and IgG in supernatants were assessed using the BD Human Flex set (total IgG #558679 and IgM #558680, BD Biosciences).
+ Open protocol
+ Expand
4

Cell Line Authentication and Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study cell lines were cultured in RPMI1640 at 37°C and 5% CO2. Staining of the cell lines with a panel of antibodies provided authentication. Mycoplasma testing was performed for all cell lines using an THP-1 reporter assay developed in our lab.52 (link) For surface expression of mICOS constructs a h/mICOS-APC (C398.4A, Biolegend, San Diego, CA) antibody was used. αCD19 construct expression was validated with a biotinylated Strep-tag II mAb (GenScript, NJ) followed by Streptavidin-PE staining (BD Pharmingen, San Diego, CA). Membrane bound αCD3 expression on TCS was detected with a DyLight-649-labeled goat-anti-mouse IgG (H+L) antibody (Jackson ImmunoResearch, West Grove, PA). mICOS-L and CD19 expression were verified using mICOS-L-PE (HK5.3) and CD19-APC (HIB19) from Biolegend. For TCS exclusion in reporter assays a mCD45.2-APC (104) from Biolegend was used. LSRFortessa™ or FACSCalibur™ (BD Bioscience, Franklin Lakes, NJ) flow cytometers were used for analysis, followed by a data analysis on the FlowJo software (Tree Star, Ashland, OR).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!